Selective elimination of glutamate activation and introduction of fluorescent proteins into a Caenorhabditis elegans chloride channel

FEBS Letters

Volumn 528, Issue 1-3, 2002, Pages 77-82

  Li, Ping ^a   Slimko, Eric M ^a   Lester, Henry A ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Electrical silencing; Ion channel

Indexed keywords

CHLORIDE CHANNEL; GLUTAMIC ACID; GREEN FLUORESCENT PROTEIN; IVERMECTIN; NICOTINIC RECEPTOR; YELLOW FLUORESCENT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BETA CHAIN; CAENORHABDITIS ELEGANS; CHANNEL GATING; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ELECTROPHYSIOLOGY; GENE INSERTION; HILL REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FAMILY; SITE DIRECTED MUTAGENESIS; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; BINDING SITES; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CHLORIDE CHANNELS; DNA, COMPLEMENTARY; FEMALE; GLUTAMIC ACID; GREEN FLUORESCENT PROTEINS; IVERMECTIN; KINETICS; LIGANDS; LUMINESCENT PROTEINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; OOCYTES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; XENOPUS LAEVIS;

CAENORHABDITIS; CAENORHABDITIS ELEGANS; INVERTEBRATA; MAMMALIA;

EID: 0037174128     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03245-3     Document Type: Article

References (24)

1. Johns D.C., Marx R., Mains R.E., O'Rourke B., Marban E. J. Neurosci. 19:1999;1691-1697.
2. White B., Osterwalder T., Keshishian H. Curr. Biol. 11:2001;R1041-1053.
3. White B.H., Osterwalder T.P., Yoon K.S., Joiner W.J., Whim M.D., Kaczmarek L.K., Keshishian H. Neuron. 31:2001;699-711.
4. Falk T., Kilani R.K., Yool A.J., Sherman S.J. Gene Ther. 8:2001;1372-1379.
5. Nadeau H., McKinney S., Anderson D.J., Lester H.A. J. Neurophysiol. 84:2000;1062-1075.
6. Scearce-Levie K., Coward P., Redfern C.H., Conklin B.R. Trends Pharmacol. Sci. 22:2001;414-420.
7. Sutherland M.L., Williams S.H., Abedi R., Overbeek P.A., Pfaffinger P.J., Noebels J.L. Proc. Natl. Acad. Sci. USA. 96:1999;2451-2455.
8. Lechner H.A., Lein E.S., Callaway E.M. J. Neurosci. 22:2002;5287-5290.
9. Slimko E., McKinney S., Anderson D., Davidson N., Lester H.A. J. Neurosci. 22:2002;7373-7379.
10. Xue H. J. Mol. Evol. 47:1998;323-333.
11. Cully D.F., Vassilatis D.K., Liu K.K., Paress P.S., Van der Ploeg L.H., Schaeffer J.M., Arena J.P. Nature. 371:1994;707-711.
12. Corringer P.J., Le Novere N., Changeux J.P. Annu. Rev. Pharmacol. Toxicol. 40:2000;431-458.
13. Etter A., Cully D.F., Liu K.K., Reiss B., Vassilatis D.K., Schaeffer J.M., Arena J.P. J. Neurochem. 72:1999;318-326.
14. Dougherty, D.A. and Lester, H.A. (2001) Nature 411, 252-253, 255.
15. Han N.L., Haddrill J.L., Lynch J.W. J. Neurochem. 79:2001;636-647.
16. Curtis L., Chiodini F., Spang J.E., Bertrand S., Patt J.T., Westera G., Bertrand D. Eur. J. Pharmacol. 393:2000;155-163.
17. Pedersen S.E., Dreyer E.B., Cohen J.B. J. Biol. Chem. 261:1986;13735-13743.
18. Gensler S., Sander A., Korngreen A., Traina G., Giese G., Witzemann V. Eur. J. Biochem. 268:2001;2209-2217.
19. Shan Q., Haddrill J.L., Lynch J.W. J. Biol. Chem. 276:2001;12556-12564.
20. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van der Oost J., Smit A.B., Sixma T.K. Nature. 411:2001;269-276.
21. Zhong W., Gallivan J.P., Zhang Y., Li L., Lester H.A., Dougherty D.A. Proc. Natl. Acad. Sci. USA. 95:1998;12088-12093.
22. Vandenberg R.J., Rajendra S., French C.R., Barry P.H., Schofield P.R. Mol. Pharmacol. 44:1993;198-203.
23. Rajendra S., Vandenberg R.J., Pierce K.D., Cunningham A.M., French P.W., Barry P.H., Schofield P.R. EMBO J. 14:1995;2987-2998.
24. Staley K., Smith R., Schaack J., Wilcox C., Jentsch T.J. Neuron. 17:1996;543-551.